Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings
about
New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical careClinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature reviewIdentification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial.Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model.STARD: How many lymph nodals needed to be dissected in corpus carcinoma?Study on Biological Characteristics and Mechanism of Paclitaxel Induced Drug Resistance in Endometrial Carcinoma Cells
P2860
Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings
@en
type
label
Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings
@en
prefLabel
Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings
@en
P2860
P1433
P1476
Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings
@en
P2093
Christine M Bestvina
Gini F Fleming
P2860
P304
P356
10.1634/THEONCOLOGIST.2016-0062
P577
2016-07-13T00:00:00Z